- About Us
- Guidelines
-
The Author ensures that the research has been conducted responsibly and ethically with adherence to all relevant regulations. read more..
- For Authors
- For Reviewer
- Manuscript Guidelines
- Membership
- Publication Ethics
-
- Journals
- Reprints
- e-Books
- Videos
- Indexing
- Contact Us
COVID-19
- Submissions
Abstract
Gastroenterology Medicine & Research
Current Advances in Immunotherapy for Colorectal Cancer
-
Open or CloseLi Ma1,2,3, Stefan Moisyadi1,2 and Wen-Ming Chu1,4,5*
1Manoa Institute for Life Science and Cancer, Honolulu, Hawaii 96813, USA
2Institute for Biogenesis Research, University of Hawaii, Honolulu, Hawaii 96822, USA
3MBBE Program, Graduate School, University of Hawaii, Honolulu, Hawaii 96822, USA
4Sbarro Institute, Philadelphia, Pennsylvania 19122, USA
5Department of Quantitative Health Sciences, University of Hawaii, Honolulu, Hawaii 96813,USA
*Corresponding author:Wen-Ming Chu, Manoa Institute for Life Science and Cancer, Honolulu, Hawaii 96813, USA
Submission: June 26, 2024;Published: July 05, 2024
ISSN 2637-7632Volume7 Issue4
Abstract
Purpose: This study aimed to briefly review the current advances in immunotherapy for colorectal
cancer.
Methods: We conducted a brief review of the latest literature.
Results: We discuss the advantages and challenges of variable forms of immunotherapy for colorectal
cancer
Conclusion: Immunotherapy holds great promise for colorectal cancer.
Keywords:mRNA; Immunotherapy; PD-1; PD-L1; Monoclonal antibody (mAb); Nanobody (Nb); CAR-T; CAR-NK; Colorectal cancer; TME
Editor In Chief
.jpg)
Signup for Newsletter
Quick Links
Editorial Board Registrations
Submit your Article
Best Paper of the Volume
Reprints
Refer a Friend
Advertise With UsOur Recent Edition
.jpg)
Top Editors
.jpg)
.bmp)
.jpg)
.png)
.jpg)
.png)
.png)
.png)
Financial Support
Sponsors
Latest e-Books
Latest Video
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in 
| Above IE 9.0 version